Literature DB >> 20169621

TGFbeta1 induces Jagged1 expression in astrocytes via ALK5 and Smad3 and regulates the balance between oligodendrocyte progenitor proliferation and differentiation.

Yueting Zhang1, Jingya Zhang, Kristina Navrazhina, Azeb Tadesse Argaw, Andleeb Zameer, Blake T Gurfein, Celia F Brosnan, Gareth R John.   

Abstract

Notch1 receptor signaling regulates oligodendrocyte progenitor differentiation and myelin formation in development, and during remyelination in the adult CNS. In active multiple sclerosis lesions, Notch1 localizes to oligodendrocyte lineage cells, and its ligand Jagged1 is expressed by reactive astrocytes. Here, we examined induction of Jagged1 in human astrocytes, and its impact on oligodendrocyte differentiation. In human astrocyte cultures, the cytokine TGFbeta1 induced Jagged1 expression and blockade of the TGFbeta1 receptor kinase ALK5 abrogated Jagged1 induction. TGFbeta2 and beta3 had similar effects, but induction was not observed in response to the TGFbeta family member activin A or other cytokines. Downstream, TGFbeta1 activated Smad-dependent signaling, and Smad-independent pathways that included PI3 kinase, p38, and JNK MAP kinase, but only inhibition of the Smad-dependent pathway blocked Jagged1 expression. SiRNA inhibition of Smad3 downregulated induction of Jagged1, and this was potentiated by Smad2 siRNA. Purified oligodendrocyte progenitor cells (OPCs) nucleofected with Notch1 intracellular signaling domain displayed a shift towards proliferation at the expense of differentiation, demonstrating functional relevance of Notch1 signaling in OPCs. Furthermore, human OPCs plated onto Jagged1-expressing astrocytes exhibited restricted differentiation. Collectively, these data illustrate the mechanisms underlying Jagged1 induction in human astrocytes, and suggest that TGFbeta1-induced activation of Jagged1-Notch1 signaling may impact the size and differentiation of the OPC pool in the human CNS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20169621      PMCID: PMC2913704          DOI: 10.1002/glia.20978

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  36 in total

Review 1.  Development. The decade of the developing brain.

Authors:  T M Jessell; J R Sanes
Journal:  Curr Opin Neurobiol       Date:  2000-10       Impact factor: 6.627

2.  Telomerase and oligodendrocyte differentiation.

Authors:  G L Caporaso; M V Chao
Journal:  J Neurobiol       Date:  2001-11-15

Review 3.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

Authors:  Yigong Shi; Joan Massagué
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

4.  Elevated levels of the chemokine GRO-1 correlate with elevated oligodendrocyte progenitor proliferation in the jimpy mutant.

Authors:  Q Wu; R H Miller; R M Ransohoff; S Robinson; J Bu; A Nishiyama
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

5.  Expression of TGFbeta2 but not TGFbeta1 correlates with the deposition of scar tissue in the lesioned spinal cord.

Authors:  C Lagord; M Berry; A Logan
Journal:  Mol Cell Neurosci       Date:  2002-05       Impact factor: 4.314

6.  Notch1 signaling plays a role in regulating precursor differentiation during CNS remyelination.

Authors:  Yueting Zhang; Azeb Tadesse Argaw; Blake T Gurfein; Andleeb Zameer; Brian J Snyder; Changhui Ge; Q Richard Lu; David H Rowitch; Cedric S Raine; Celia F Brosnan; Gareth R John
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-23       Impact factor: 11.205

7.  Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation.

Authors:  Gareth R John; Sai Latha Shankar; Bridget Shafit-Zagardo; Aldo Massimi; Sunhee C Lee; Cedric S Raine; Celia F Brosnan
Journal:  Nat Med       Date:  2002-09-23       Impact factor: 53.440

8.  Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.

Authors:  N J Laping; E Grygielko; A Mathur; S Butter; J Bomberger; C Tweed; W Martin; J Fornwald; R Lehr; J Harling; L Gaster; J F Callahan; B A Olson
Journal:  Mol Pharmacol       Date:  2002-07       Impact factor: 4.436

Review 9.  Smad regulation in TGF-beta signal transduction.

Authors:  A Moustakas; S Souchelnytskyi; C H Heldin
Journal:  J Cell Sci       Date:  2001-12       Impact factor: 5.285

10.  Notch1 control of oligodendrocyte differentiation in the spinal cord.

Authors:  Stephane Genoud; Corinna Lappe-Siefke; Sandra Goebbels; Freddy Radtke; Michel Aguet; Steven S Scherer; Ueli Suter; Klaus-Armin Nave; Ned Mantei
Journal:  J Cell Biol       Date:  2002-08-19       Impact factor: 10.539

View more
  28 in total

1.  Investigation of astrocyte - oligodendrocyte interactions in human cultures.

Authors:  Gareth R John
Journal:  Methods Mol Biol       Date:  2012

Review 2.  Oligodendrocyte fate after spinal cord injury.

Authors:  Akshata Almad; F Rezan Sahinkaya; Dana M McTigue
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

3.  Astrocyte-derived endothelin-1 inhibits remyelination through notch activation.

Authors:  Timothy R Hammond; Ana Gadea; Jeff Dupree; Christophe Kerninon; Brahim Nait-Oumesmar; Adan Aguirre; Vittorio Gallo
Journal:  Neuron       Date:  2014-02-05       Impact factor: 17.173

Review 4.  Promoting myelin repair and return of function in multiple sclerosis.

Authors:  Jingya Zhang; Elisabeth G Kramer; Linnea Asp; Dipankar J Dutta; Kristina Navrazhina; Trinh Pham; John N Mariani; Azeb Tadesse Argaw; Carmen V Melendez-Vasquez; Gareth R John
Journal:  FEBS Lett       Date:  2011-08-18       Impact factor: 4.124

5.  Migration of oligodendrocyte progenitor cells is controlled by transforming growth factor β family proteins during corticogenesis.

Authors:  Youngshik Choe; Trung Huynh; Samuel J Pleasure
Journal:  J Neurosci       Date:  2014-11-05       Impact factor: 6.167

6.  Glioprotective Effect of Resveratrol: an Emerging Therapeutic Role for Oligodendroglial Cells.

Authors:  Priscila Machado Rosa; Leo Anderson Meira Martins; Diogo Onofre Souza; André Quincozes-Santos
Journal:  Mol Neurobiol       Date:  2017-04-29       Impact factor: 5.590

7.  Leukocyte Gene Expression and Plasma Concentration in Multiple Sclerosis: Alteration of Transforming Growth Factor-βs, Claudin-11, and Matrix Metalloproteinase-2.

Authors:  Gholamreza Hassanzadeh; Samaneh Hosseini Quchani; Mohammad Ali Sahraian; Farid Abolhassani; Mohammad Ali Sadighi Gilani; Masoomeh Dehghan Tarzjani; Fatemeh Atoof
Journal:  Cell Mol Neurobiol       Date:  2016-01-14       Impact factor: 5.046

8.  STAT3-mediated astrogliosis protects myelin development in neonatal brain injury.

Authors:  Hiroko Nobuta; Cristina A Ghiani; Pablo M Paez; Vilma Spreuer; Hongmei Dong; Rose A Korsak; Armine Manukyan; Jiaxi Li; Harry V Vinters; Eric J Huang; David H Rowitch; Michael V Sofroniew; Anthony T Campagnoni; Jean de Vellis; James A Waschek
Journal:  Ann Neurol       Date:  2012-08-31       Impact factor: 10.422

9.  Differentiation of oligodendrocyte precursors is impaired in the prefrontal cortex in schizophrenia.

Authors:  Sarah A Mauney; Charmaine Y Pietersen; Kai-C Sonntag; Tsung-Ung W Woo
Journal:  Schizophr Res       Date:  2015-11-14       Impact factor: 4.939

10.  Differential modulation of the oligodendrocyte transcriptome by sonic hedgehog and bone morphogenetic protein 4 via opposing effects on histone acetylation.

Authors:  Muzhou Wu; Marylens Hernandez; Siming Shen; Jennifer K Sabo; Dipti Kelkar; Ju Wang; Robert O'Leary; Greg R Phillips; Holly S Cate; Patrizia Casaccia
Journal:  J Neurosci       Date:  2012-05-09       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.